Nanomedicine and Nanotechnology: Recent Advances and Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 41
Special Issue Editor
Interests: drug delivery; pharmaceutics; oral delivery; controlled and sustained release; pharmaceutical technology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology continues to redefine the frontiers of pharmaceutical sciences, enabling breakthroughs in targeted drug delivery, diagnostic precision, and therapeutic efficacy that were once deemed unattainable.
This Special Issue aims to curate a collection of high-impact research articles and authoritative reviews that exemplify innovation, originality, and transformative potential at the nexus of nanomaterials, biomedical engineering, and pharmaceutical applications. We seek contributions that illuminate significant advances in the design, synthesis, characterization, and clinical translation of nanoscale systems—spanning smart stimuli-responsive nanocarriers, multifunctional theranostic platforms, nano-bio interaction studies, and emerging applications in gene editing, immunomodulation, or precision medicine. Submissions should emphasize rigorous scientific methodology, clear clinical relevance, and a forward-looking perspective capable of guiding future research trajectories. Priority areas include but are not limited to novel drug delivery systems engineered for spatial-temporal control; nanodiagnostics integrating sensing, imaging, and therapy; mechanistic studies addressing biocompatibility, toxicity, and regulatory pathways; and scalable manufacturing strategies bridging laboratory innovation to clinical practice.
As a curated feature issue, we particularly welcome comprehensive reviews or original research from established researchers whose work has demonstrably influenced the nanomedicine landscape. All submissions will undergo a stringent peer review to ensure scholarly excellence, methodological robustness, and alignment with the journal’s commitment to cutting-edge pharmaceutical nanotechnology. By synthesizing pioneering insights from global experts, this issue aspires to become an enduring reference for academics, clinicians, and industry partners advancing nanoscale solutions to unmet medical challenges.
We cordially invite you to contribute your most impactful work to this timely forum, fostering collaborative progress toward next-generation nanotherapeutics.
Prof. Dr. Wei Wu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- novel drug delivery systems engineered for spatial-temporal control
- nanodiagnostics integrating sensing, imaging, and therapy
- mechanistic studies addressing biocompatibility, toxicity, and regulatory pathways
- scalable manufacturing strategies bridging laboratory innovation to clinical practice
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
